1. Home
  2. RECT vs CVM Comparison

RECT vs CVM Comparison

Compare RECT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.30

Market Cap

19.1M

Sector

N/A

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.38

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
CVM
Founded
1997
1983
Country
Singapore
United States
Employees
111
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
21.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RECT
CVM
Price
$1.30
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.1K
678.1K
Earning Date
03-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.74
N/A
Revenue Growth
N/A
65.45
52 Week Low
$1.00
$0.89
52 Week High
$4.98
$13.48

Technical Indicators

Market Signals
Indicator
RECT
CVM
Relative Strength Index (RSI) 46.96 34.72
Support Level $1.02 $0.89
Resistance Level $1.30 $1.86
Average True Range (ATR) 0.11 0.15
MACD 0.00 0.08
Stochastic Oscillator 60.97 1.02

Price Performance

Historical Comparison
RECT
CVM

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: